What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?

Autor: Francesco Autore, Stefania Bramanti, Federica Lessi, Idanna Innocenti, Eugenio Galli, Serena Rocchi, Rossella Ribolla, Daniele Derudas, Stefania Oliva, Paola Stefanoni, Magda Marcatti, Angelo Schenone, Giorgio La Nasa, Claudia Crippa, Elena Zamagni, Marcello Riva, Rita Mazza, Daniele Mannina, Simona Sica, Andrea Bacigalupo, Luca Laurenti

Publikováno v: Haematologica, Vol 109, Iss 3 (2023)

Autologous peripheral blood stem cell transplantation (aPBSCT) provides optimal outcomes in POEMS syndrome but the definition of the best treatment before aPBSCT remains to be defined because of the rarity of the disease and the heterogeneity of publ

Externí odkaz: https://doaj.org/article/49923cb4e2704333b3669372233d26c3

SOCIALRES PROJECT – FOSTERING ENERGY DEMOCRACY THROUGH SOCIAL INNOVATION

Autor: Silvia Caneva, Pablo Alonso, Iban Lizarralde, Isabelle Valentin, Audrey Abi Akle, Mikhail Hamwi, Volker Kromrey, Dimitri Vedel, Annika Wotjen, Andreas Schneller, Lena Domröse, Alice Ferrari, Claudia Crippa, Eleanor Denny, James Carroll, Maria Regidor, Sofía Mulero, Iban Lacoste, Rodrigo Ruiz, Nuno Brito Jorge, Mariana Teixeira, Karl Harder, Tom Harwood, Tijana Šimek, Daniela Leonte, Mihai Policar

Publikováno v: EUPVSEC

37th European Photovoltaic Solar Energy Conference and Exhibition; 2038-2041
SocialRES aims at fostering energy democracy through social innovations defined as cooperatives, aggregators of renewable energy and crowdfunding platforms. The photovo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c05e72c155dc06a4de3d38f659d59316

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

Autor: Paola Tacchetti, Lucia Pantani, Francesca Patriarca, Maria Teresa Petrucci, Elena Zamagni, Luca Dozza, Monica Galli, Francesco Di Raimondo, Claudia Crippa, Mario Boccadoro, Simona Barbato, Patrizia Tosi, Franco Narni, Vittorio Montefusco, Nicoletta Testoni, Antonio Spadano, Carolina Terragna, Norbert Pescosta, Giulia Marzocchi, Claudia Cellini, Piero Galieni, Sonia Ronconi, Marco Gobbi, Lucio Catalano, Antonio Lazzaro, Giovanni De Sabbata, Clotilde Cangialosi, Fabrizio Ciambelli, Pellegrino Musto, Francesca Elice, Michele Cavo, Renato Fanin, Roberto Foa', Alessandro Rambaldi, Giuseppe Rossi, Pietro Leoni, Paolo Corradini, Giuseppe Torelli, Giuseppe Fioritoni, Sergio Cortelazzo, Giorgio Lambertenghi Deliliers, Giorgio La Nasa, Alfonso Zaccaria, Paolo De Fabritiis, Nicola Cascavilla, Alberto Bosi, Gianpietro Semenzato, Luigi Gugliotta, Filippo Gherlinzoni, Emanuele Angelucci, Massimo Fabrizio Martelli, Maria Concetta Petti, Giuseppe Leone, Angelo Michele Carella, Fabio Ciceri, Armando Santoro, Felicetto Ferrara, Francesco Nobile, Alfonso Maria D'Arco, Alessandro Levis, Luciano Guardigni, Andrea Gallamini, Pier Paolo Fattori, Sergio Morandi, Dino Amadori, Bruno Rotoli, Salvatore Mirto, Giorgio Paladini, Ruggero Mozzana, Graziella Pinotti, Francesco Rodeghiero, Nicola Cantore, Vincenzo Pavone, Enrico Maria Pogliani, Anna Marina Liberati, Ignazio Majolino, Sergio Amadori, Francesco Lauria, Massimo Aglietta, Giovanni Quarta, Sergio Storti, Fortunato Morabito, Silvana Franca Capalbo, Alessandro Massimo Gianni, Vincenzo Mettivier, Vittorio Rizzoli, Carlo Bernasconi, Giuseppe Visani, Michele Pizzuti, Giacinto La Verde, Giuseppe Avvisati, Maurizio Longinotti, Eugenio Gallo, Franco Dammacco, Domenico Russo, Andrea Bacigalupo, Caterina Musolino

Publikováno v: The Lancet Haematology. 7:e861-e873

Background: The phase 3 GIMEMA-MMY-3006 trial, which compared bortezomib, thalidomide, and dexamethasone (VTD) combination therapy with thalidomide and dexamethasone (TD) as induction therapy before and consolidation therapy after double autologous h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d247cf6931cb796a2568e2552250ca02
https://doi.org/10.1016/s2352-3026(20)30323-9

Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia

Autor: Doriana Gramegna, Chiara Pagani, Angela Passi, Erika Borlenghi, Chiara Cattaneo, Claudia Crippa, Francesca Schieppati, Margherita Oberti, Daniela Bellotti, Margherita Sciumé, Elisa Cerqui, Cecilia Carbone, Daniela Dalceggio, Giuseppe Rossi, Diego Bertoli, Mirko Farina, Alessandra Tucci, Silvana Archetti, Giulia Soverini

Publikováno v: Hematological Oncology. 38:754-762

Consolidation treatment in acute myeloid leukemia (AML) patients achieving complete remission (CR) is warranted. High-dose cytarabine (HDAC) is considered first choice in favorable risk and an option in intermediate-risk AML. However, its optimal dos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d77c6f6d4220f03991c44aa55e266b
https://doi.org/10.1002/hon.2806

COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

Autor: Carlos Vallejo Llamas, Mohsen Al Zahrani, Per Ljungman, Kim Orchard, María J. Jiménez, María Calbacho, Beatriz Aguado, Jose Luis Lopez Lorenzo, Safiye Koçulu Demir, Rafael de la Cámara, Aliénor Xhaard, Rocio Parody Porras, Maria Laura Fox, Rodrigo Martino Bofarull, Daniele Vallisa, José Luis Piñana, Gloria Tridello, Mi Kwon, Angel Cedillo, Anna De Grassi, Nina Knelange, Jane F. Apperley, Malgorzata Mikulska, Jan Styczyński, Stephan Mielke, Nicolaus Kröger, Lucía López-Corral, Fabio Ciceri, Claudia Crippa, Ana Berceanu

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Digital.CSIC. Repositorio Institucional del CSIC
instname
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Scientia
Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA

© The Author(s) 2021.
This study reports on 382 COVID-19 patients having undergone allogeneic (n = 236) or autologous (n = 146) hematopoietic cell transplantation (HCT) reported to the European Society for Blood and Marrow Transplantation (EBMT

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6300017a7347536ab040a1ad22cfea5a
http://hdl.handle.net/10261/261277